T0901317 10mg 10mg | Purity Not Available
Adooq Bioscience
T0901317 is a potent, high affinity liver X receptor (LXR) agonist (EC50 ~ 50 nM, Kd values are 7 and 22 nM for LXR-?? and LXR-?? respectively).
More Information Supplier PageT0901317 is a potent, high affinity liver X receptor (LXR) agonist (EC50 ~ 50 nM, Kd values are 7 and 22 nM for LXR-?? and LXR-?? respectively).
More Information Supplier PageSB-649868 is an orexin receptor antagonist in development by GlaxoSmithKline.
More Information Supplier PageSB-649868 is an orexin receptor antagonist in development by GlaxoSmithKline.
More Information Supplier PageSB-649868 is an orexin receptor antagonist in development by GlaxoSmithKline.
More Information Supplier PageSB-649868 is an orexin receptor antagonist in development by GlaxoSmithKline.
More Information Supplier PagePKC 412 is a broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms (??, ??, ??), PDFR??, VEGFR2, Syk, PKC??, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR. Displays potent antitumor activity.
More Information Supplier PagePKC 412 is a broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms (??, ??, ??), PDFR??, VEGFR2, Syk, PKC??, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR. Displays potent antitumor activity.
More Information Supplier PagePKC 412 is a broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms (??, ??, ??), PDFR??, VEGFR2, Syk, PKC??, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR. Displays potent antitumor activity.
More Information Supplier PagePKC 412 is a broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms (??, ??, ??), PDFR??, VEGFR2, Syk, PKC??, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR. Displays potent antitumor activity.
More Information Supplier PageAvanafil is a PDE5 Inhibitor for the Treatment of Erectile Dysfunction
More Information Supplier Page